Product Images Oxcarbazepine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Oxcarbazepine NDC 60429-062 by Golden State Medical Supply, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
OXCARBAZEPINE is a medication available in tablet form, with a strength of 150mg. The package contains 500 tablets. Dosage information is provided in the package insert. A medication guide from Pharmagrt is also provided to the patient and can be printed at https://igsms.us/. The tablets should be stored at a temperature between 20°C and 25°C (68°F-77°F), with excursions permitted between 15°C and 30°C (59°F-86°F). The rest of the text appears to be gibberish.*
This is a description for a medication called OXCARBAZEPINE, which is available in the form of tablets. The package contains 500 tablets with a strength of 300 mg. The text also includes a reference to a medication guide that needs to be printed for each patient. No further useful information could be obtained from the text.*
This is a pharmaceutical label for Oxcarbazepine Tablets. The NDC code, dosage strength, and quantity are provided. The medication should be stored in a tight container and kept away from children. Manufacturing and packaging information is also provided.*
The text provides the results of a Tog-rank test with a p-value of 0.0001. Additionally, there is a chart with two rows displaying 'T' characters and numbers 0-9, and two columns labeled 'Day2' and 'Day11' with times of 8am for each. The chart also shows two treatment groups: Oxcarbazepine and Placebo. No further information is available.*
The text describes the seizure rate for two treatment groups, Oxcarbazepine and Placebo, over a period of time. The log-rank test resulted in a p-value of 0.046, suggesting a significant difference between the two groups. The x-axis represents the number of days from the first dose to the first seizure, while the y-axis shows the number of seizures.*
This appears to be a survival plot depicting the cumulative survival of two groups (HIGH and LOW) over a specified period. The graph shows the percentage of surviving participants at different time points ranging from 0 to 130 days. The log-rank test was employed to compare the survival curves of both groups and the p-value was found to be 0.0001.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.